Ursprung des Netzwerks ersten Grades von Nisha Varma
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
BOA Biomedical, Inc.
 BOA Biomedical, Inc. Medical SpecialtiesHealth Technology BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis.
3
| Private Company | Medical Specialties | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nisha Varma
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Auris Health, Inc.
 Auris Health, Inc. Medical SpecialtiesHealth Technology Auris Health, Inc. develops robotics technology for medical applications. The company was founded by Frederic H. Moll, Hariharan Sundram and Christopher J. P. Velis and is headquartered in Redwood City, CA. | Medical Specialties | Founder | |
Audax Medical, Inc.
 Audax Medical, Inc. Medical SpecialtiesHealth Technology Audax Medical, Inc. operates as an orthopedic company that focuses on the development of a regenerative biomaterial. It develops Arxis, a self-assembling bioresorbable nanocomposite that can be used in minimally-invasive orthopedic reconstructive surgery. The company was founded by Mark A. Johanson, Christopher J. P. Velis in 2009 and is headquartered in Concord, MA. | Medical Specialties | Founder | |
| Yale University | College/University | Doctorate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Biotechnology | Chief Executive Officer | |
Emulate, Inc.
 Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Drugstore Chains | Founder | |
Medcap Growth Equity GP LP
 Medcap Growth Equity GP LP Investment Trusts/Mutual FundsMiscellaneous MedCap Growth Equity GP LP operates as a venture capital fund. The company is headquartered in Cambridge, MA. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Questrom School of Business | College/University | Masters Business Admin | |
Miraki Innovation, Inc.
 Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder | |
Unravel Biosciences, Inc.
 Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation. | Biotechnology | Founder | |
Arctic Fox Biomedical , Inc.
 Arctic Fox Biomedical , Inc. Miscellaneous Commercial ServicesCommercial Services Arctic Fox Biomedical, Inc. develops control of fat cells for aesthetic and therapeutic applications. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | Private Equity Investor | |
| University of Massachusetts Amherst | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 13 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 5 |
| Retail Trade | 2 |
| Miscellaneous | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 6 |
| Founder | 6 |
| Undergraduate Degree | 3 |
| Private Equity Investor | 2 |
| Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Christopher J. P. Velis | 10 |
| Donald Ingber | 4 |
| Earl Kishida | 1 |
- Börse
- Insiders
- Nisha Varma
- Unternehmensverbindungen
